Antibodies to glutamic acid decarboxylase (GADA) as markers of risk for development of insulin-dependent diabetes mellitus;Przeciwciała skierowane przeciwko dekarboksylazie kwasu glutaminowego (antyGAD) jako marker ryzyka rozwoju cukrzycy insulinozaleznej.

Przegla̧d lekarski

Volumn 55, Issue 6, 1998, Pages 315-319

  Kretowski, A ^a   Szelachowska, M ^a   Kowalska, I ^a   Peczynska J ^a   Urban, M ^a   Kinalska, I ^a  

^a Kliniki Endokrynologii Akademii Medycznej w Bia ymstoku

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METHODOLOGY; MIDDLE AGED; PANCREAS ISLET; PREDICTION AND FORECASTING; PRESCHOOL CHILD; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 0032254160     PISSN: 00332240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)